Call 413.540.1234 to
schedule an appointment
CONCERN/EAP: 413.534.2625
Billing questions? Call: 413.540.1212
CRISIS: 413.733.6661

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Many Supplements Still Contain Dangerous Stimulants: StudyTapping Into TelehealthMenthol Cig Ban Didn't Spur Black Market Sales: StudyHip-Hop Loaded With Pot, Cigarette ReferencesWhite House Wants Prices in Drug Ads, But Big Pharma Fights BackMany Supplements Contain Unapproved, Dangerous Ingredients: StudyE-Cigs Continue to Spark Debate Over Health Risks/BenefitsClinical Trials Need More VolunteersGetting Your Medical Records Might Not Be EasyMost People Don't Know if They Have Genetic Risk for CancerConsumer Reports Says Warnings About Tainted Beef Don't Go Far EnoughThe Physician Assistant Will See You NowCoffee Shop Workers on Front Lines of Opioid CrisisDozens of Medical Groups Join Forces to Improve DiagnosesDoes Big Pharma Hike Prices When Meds Are in Short Supply?FDA Gets Tough on Juul, Other E-Cigarette Makers'No Documented Reason' for 1 in 3 Outpatient Opioid Rxs: StudyUrgent Care Centers Ease ER Burden in U.S.Poor Health Care Linked to 5 Million Deaths Worldwide a Year'Million Hearts' Project Aims to Prevent 1 Million Cardiac CrisesDoctor Burnout Likely to Impair CareHomelessness Takes Toll on Kids' Health Even Before They're BornFDA Warns of Dangers of Liquid Nitrogen in Food, DrinksStates Struggle With Onslaught of Opioid OD DeathsAHA: Why More Americans Are Kicking the Smoking HabitMonitoring System for Underage Tobacco Sales Falls Short: StudyHundreds of Human, Pet Homeopathy Products RecalledAHA: CPR Training at School Now Required in 38 StatesGovernment Rules Aimed at Curbing Opioid Prescriptions May Have BackfiredGut Enzyme Could Help Solve U.S. Blood ShortagesHealth Tip: Making an Emergency CallFrom Pigs to Peacocks, What's Up With Those 'Emotional-Support Animals'?Global Aid Programs Shortchange Teen Health Needs: StudyDoctors Write Fewer Opioid Scripts After Learning of Overdose DeathHow to Become an Educated PatientU.S. Murder, Suicide Rates Climbing AgainTo Boost Colon Cancer Screening, Use the MailMajority in U.S. Support Medical Pot, Think It Could Fight Opioid CrisisWhey Powder Blamed for Salmonella Tied to Ritz Crackers, Goldfish: FDAToo Few Americans Getting Screened for Cancer: CDCYou Have 11 Seconds to Tell Your Doc What's WrongFDA Warns of Deaths Tied to Tainted Synthetic PotWhere Are Opioid Painkillers Prescribed the Most?In the ICU, Patients' Relatives Often Mum About Care ConcernsResetting E-Prescriptions for Opioids Helps Curb Use: StudyHealth Tip: If You're 45 or Older, Get Screened for Colorectal CancerRed Cross Issues Nationwide Call for Blood DonationsDoctor Burnout Widespread, Helps Drive Many Medical ErrorsWarming Climate, More AC -- and More Unhealthy Smog AheadEven at 'Safe' Levels, Air Pollution May Boost Diabetes Risk
Questions and AnswersLinksBook Reviews
Related Topics

Take Early Clinical Trials With a Grain of Salt

HealthDay News
by -- Robert Preidt
Updated: Feb 22nd 2018

new article illustration

THURSDAY, Feb. 22, 2018 (HealthDay News) -- More than one-third of early clinical trials exaggerate positive findings and may give patients false hope, a new study suggests.

Researchers reviewed data from 930 clinical trials published in 10 leading medical journals between early 2007 and mid-2015. The investigators found that a significant number of early trials reported effects that were 2.7 times greater than what was eventually seen in later trials.

"This phenomenon of exaggerated early results was present in a whopping 37 percent of the studies we reviewed," said study author Dr. Fares Alahdab, a research fellow with the Mayo Clinic's Evidence-Based Practice Center.

"Physicians and patients should be cautious about new or early clinical trial evidence. Exaggerated results could lead to false hope as well as possibly harmful effects," Alahdab added in a Mayo news release.

The review focused on clinical trials for drugs or devices targeting chronic conditions, including cancer, stroke, heart disease, diabetes and kidney disease.

According to Dr. M. Hassan Murad, director of Mayo's Evidence-Based Practice Center, "Often, patients are living with more than one chronic condition, and they and their doctors watch for research about new treatments. They need to be aware that the effect seen in earlier trials may not bear out over time and may be much more modest."

Murad noted that "some people may think this is an anti-innovation message."

But, he added, "To the contrary, we welcome new treatments. We just want people to know that the benefit seen in real practice, when treatments are given to people with various co-morbidities [multiple illnesses] and in different settings, may be smaller than what was seen in the earliest clinical trials."

According to the U.S. National Institutes of Health, clinical trials are key to all medical advances. They look at new ways to prevent, detect or treat disease. They can involve new drugs or new combinations of drugs, new ways of doing surgery, and new medical devices, among other topics.

The study was published online Feb. 21 in the journal Mayo Clinic Proceedings.

More information

The U.S. National Institutes of Health has more on clinical trials.